A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial
Brigid M Lynch, Nga H Nguyen, Melissa M Moore, Marina M Reeves, Dori E Rosenberg, Terry Boyle, Jeff K Vallance, Shakira Milton, Christine M Friedenreich, Dallas R English
CANCER | WILEY | Published : 2019
BACKGROUND: The benefits of an active lifestyle after a breast cancer diagnosis are well recognized, but the majority of survivors are insufficiently active. The ACTIVATE Trial examined the efficacy of an intervention (use of the Garmin Vivofit 2 activity monitor coupled with a behavioral feedback and goal-setting session and 5 telephone-delivered health coaching sessions) to increase moderate to vigorous physical activity (MVPA) and reduce sedentary behavior in breast cancer survivors. METHODS: This randomized controlled trial recruited 83 inactive, postmenopausal women diagnosed with stage I-III breast cancer who had completed primary treatment. Participants were randomly assigned to the i..View full abstract
Awarded by World Cancer Research Fund-International
Awarded by National Breast Cancer Foundation Fellowship
Awarded by National Health and Medical Research Council Early Career Fellowship
This work was enabled by a grant from the World Cancer Research Fund-International (2015/1397). Brigid M. Lynch was supported by a National Breast Cancer Foundation Fellowship (ECF-15-012); Terry Boyle was supported by a National Health and Medical Research Council Early Career Fellowship (1072266); Jeff. K. Vallance was supported by the Canada Research Chairs program.